Pasithea Therapeutics Corp.
KTTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001841330
No open-market purchases or sales by Pasithea Therapeutics Corp. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $8.66M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Pasithea Therapeutics Corp. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 10 | 9 | −1 |
| Shares | 656.0K | 819.1K | +163.1K (+24.9%) |
| Value | $662.1K | $1.03M | +$369.9K (+55.9%) |
New holders (1)
Institutions that held Pasithea Therapeutics Corp. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Old Well Partners, LLC | 33,000 | $42.0K | 0.03% |
Sold out (2)
Institutions that held Pasithea Therapeutics Corp. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Virtu Financial LLC | 14,571 | $15.0K |
| StoneX Group Inc. | 12,000 | $12.1K |